Workshop F – From Access to Exit: Designing Global Program Closure, Patient Transition & Long-Term Access Strategies

1:30 pm - Tuesday 23rd March 2027

  • Navigating country-by-country closure requirements, reimbursement delays and differing patient continuity obligations across global markets.
  • Determining how and when programs should close in markets where launch plans, regulatory outcomes or funding assumptions change.
  • Learning from successful and unsuccessful program exits, including the operational, regulatory and stakeholder challenges that emerge once an access program reaches the end of its lifecycle.
  • Benchmarking how organizations are handling program winddown, patient communications, physician engagement and long-term access commitments globally

Speakers:

Senior Director - Medical Affairs, Expanded Access & Global Diagnostics
Alnylam
Director, Medical Affairs Operations Lead
Beam Therapeutics Inc.